Desmopressin for Bedwetting: Treatment Recommendations

Introduction to Desmopressin Treatment

Desmopressin is an evidence-based first-line pharmacological treatment for bedwetting that reduces wet nights by approximately 30-40% during active treatment, with oral formulations strongly preferred over nasal spray due to safety concerns 1, 2

Desmopressin works best in children with nocturnal polyuria (nighttime urine production >130% of expected bladder capacity for age) and normal bladder function (maximum voided volume >70% of expected bladder capacity) 1, 2
Children in whom alarm therapy has failed are also appropriate candidates for desmopressin 3

The American Academy of Pediatrics recommends a dose of 0.2-0.4 mg taken at least 1 hour before sleep 1, 4, 5
The maximum renal concentrating effect occurs 1-2 hours after administration 1, 4
The dose is not influenced by body weight or age 1, 4

The American Urological Association mandates a fluid restriction of 200 ml (6 ounces) or less in the evening, with no drinking until morning, to prevent water intoxication 1, 2, 5, 6
Polydipsia (excessive thirst/drinking) is an absolute contraindication for desmopressin 1, 2, 5, 6
Nasal spray formulations are strongly discouraged due to higher risk of water intoxication with hyponatremia and convulsions 1, 2, 5, 6

Regular short drug holidays are recommended to assess whether medication is still needed 1, 4, 5, 6
The effect of desmopressin is immediate, so families can quickly determine ongoing necessity 1, 4

Approximately 30% of children become full responders (completely dry) during treatment with desmopressin 2
40% achieve partial response (significant reduction in wet nights) 2

Alarm therapy may produce more sustained long-term benefits than desmopressin, with a success rate of approximately 66% and better outcomes after treatment stops 5

If standard desmopressin treatment fails and there is evidence of detrusor overactivity, consider adding anticholinergics (such as tolterodine, oxybutynin, or propiverine) 1, 4, 3, 5
Approximately 40% of treatment-resistant children respond to this combination 1, 4, 3

Before starting desmopressin, a urine dipstick is mandatory to rule out glycosuria and proteinuria, and a frequency-volume chart for at least 2 days is recommended to document nocturnal polyuria 7

Using nasal spray formulation is not recommended due to the higher risk of hyponatremia 1, 2, 5, 6
Inadequate fluid restriction counseling can lead to water intoxication, so families must understand the 200 ml limit 1, 2, 5, 6
Continuing desmopressin indefinitely without drug holidays prevents assessment of ongoing need 1, 4, 5, 6
Expecting cure rather than symptom control can lead to disappointment, as the curative potential of desmopressin is low 2, 3
Not screening for polydipsia is a critical mistake, as it is an absolute contraindication for desmopressin 1, 2, 5, 6

The American Urological Association recommends considering adding anticholinergics, such as tolterodine, oxybutynin, or propiverine, to desmopressin if detrusor overactivity is present, with approximately 40% of treatment-resistant patients responding to combination therapy 8

The International Continence Society suggests that morning furosemide (0.5 mg/kg) plus desmopressin may benefit patients with desmopressin-resistant nocturnal polyuria, shifting sodium and osmotic excretion to daytime and reducing nocturnal diuresis, with 9 of 12 resistant patients achieving continence in one pilot study 8